Abstract:Objective To explore the in vivo effect of microRNA (miRNA,miR)-106b on joint destruction in collagen-induced arthritic (CIA) mice.Methods Forty male DBA/1 mice (8-10 weeks of age) were randomly divided into fourgroups:sham control [no collagen Ⅱ injection/phosphate buffer (PBS)-only treatment],lentivirus-NC control (collagen Ⅱ injection/lentivirus treatment),mimic (collagen Ⅱ injection/miR-106b mimics) and inhibitor (collagen Ⅱ injection/miR-106b inhibitor).CIA mice are developed by injecting DAB/1 mice with bovine type Ⅱ collagen containing Freund's Adjuvant.The level of miR-106b was evaluated via reverse transcriptase-polymerase chain reaction (RT-PCR).Morphological changes in the ankle joints were assessed via μCT.Mature osteoclasts were identified using tartrate-resistant acid phosphatase (TRAP) staining.Expression of receptor activator of nuclear factor-κB ligand (RANKL) and bone protection element (OPG) were identified using enzyme linked immunosorbent assay (ELISA).Results CIA mice were found to have increased miR-106b expression and CIA-associated bone loss.As assessed in the three-dimensional μCT reconstructions,severe bone destruction was observed in CIA mice.Treatment with miR-106b inhibitor significantly mitigated CIA-induced bone resorption compared with the NC groups.The miR-106b inhibitor treatment induced an obvious increase in bone volume [(6.85 ± 0.24) mm3 vs.(5.61 ± 0.35) mm3,P ＜ 0.01],bone volume fraction [(22.52± 0.62)％ vs.(16.26± 1.42)％,P＜ 0.01],trabecular thickness [(0.31 ±0.06) mm vs (0.24±0.06) mm,P＜0.01],and a marked decrease in bone surface to volume ratio [(9.46±2.02)/mm vs.(13.32 ± 1.85)/mm,P ＜ 0.01],when compared with that in NC groups.Histological results showed that NC-and miR-106b mimic-treated groups had larger numbers of TRAP-positive cells located on eroded bone surfaces than in the vehicle-treated group.However,few TRAP-positive cells presented in the miR-106b inhibitor treated group.Serum from CIA mice was then examined via ELISA analysis and showed serum RANKL levels to be significantly increased when compared to the control group,whereas OPG levels were not significantly altered relative to the control.In miR-106b inhibitor treated mice,RANKL levels were significantly down-regulated,while OPG levels were up-regulated.Consequently,the RANKL/OPG ratio increased in CIA mice and was reduced in miR-106b inhibitor treated mice.Conclusion In summary,the results in the current study clearly demonstrated that miR-106b is involved in the development of CIA-induced bone destruction and blocking of miR-106b attenuated bone resorption in CIA mice.

MicroRNA-106b inhibitor attenuates joint destruction in collagen-induced arthritic mice by regulating receptor activator of nuclear factor-κB ligand/bone protection element signal pathway

Downregulation of Mir-106B Attenuates Inflammatory Responses and Joint Damage in Collagen-Induced Arthritis

Mesenchymal Stem Cells Promote the Osteogenesis in Collagen-Induced Arthritic Mice Through the Inhibition of TNF-α.

Mir-145-5p Increases Osteoclast Numbers in Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin

Polymorphonuclear Myeloid-Derived Suppressor Cells Play a Proinflammatory Role Via TNF-α+ B Cells Through BAFF/BTK/NF-κB Signalling Pathway in the Pathogenesis of Collagen-Induced Arthritis Mice

Co-Expression of Il-18 Binding Protein and Il-4 Regulates Th1/Th2 Cytokine Response in Murine Collagen-Induced Arthritis

The Mir-1906 Mimic Attenuates Bone Loss in Osteoporosis by Down-Regulating the TLR4/MyD88/NF‐κB Pathway

Effect of the Interaction Between MiR-200b-3p and DNMT3A on Cartilage Cells of Osteoarthritis Patients.

Downregulated Microrna‐106 Inhibits Apoptosis and Promotes Proliferation and Differentiation of Chondrocytes in Osteoarthritis Through Restraining the Activation of Wnt/β‐catenin Pathway

Silencing of miR-101 Prevents Cartilage Degradation by Regulating Extracellular Matrix-related Genes in a Rat Model of Osteoarthritis.

MiR-204/-211 double knockout exacerbates rheumatoid arthritis progression by promoting splenic inflammation

Mir-381-3p Participates in Chondrogenesis and Cartilage Degradation by Alleviating Collagen 2 Expression and Enhancing Mmp13 Expression

Cannabinoid Receptor 2 Agonist Prevents Local and Systemic Inflammatory Bone Destruction in Rheumatoid Arthritis

MicroRNA-1 small nucleic acid drugs attenuate the progression of osteoarthritis by downregulating Indian hedgehog

Inhibition of Microrna-495 Suppresses Chondrocyte Apoptosis Through Activation of the NF-κB Signaling Pathway by Regulating CCL4 in Osteoarthritis

Silencing miR-146a-5p Protects against Injury-Induced Osteoarthritis in Mice

MicroRNA-26b-5p Alleviates Murine Collagen-Induced Arthritis by Modulating Th17 Cell Plasticity

The experimental study on the effect of rhTNFR:Fc and methtotrexate-rhTNFR:Fc on joint destruction of collagen-induced arthritis rat

Mir-146B Accelerates Osteoarthritis Progression by Targeting Alpha-2-macroglobulin

Upregulation of Microrna-335 Abrogates Bone Loss in Arthritic Ovariectomized Mice Via Inhibition of RANKL-mediated FASN/ERα Signaling Pathway

A Selective CB2 Agonist Protects Against the Inflammatory Response and Joint Destruction in Collagen-Induced Arthritis Mice.